First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC

Inclusion Criteria:

Histologically confirmed non-small cell bronchogenic carcinoma, (adenocarcinoma, or large cell carcinoma)
Patients who have newly diagnosed unresectable stage III or stage IV disease are eligible.
Must be at least 70 years of age
Must have measurable disease by CT scan
Must be able to be up and about and care for themselves
May not have received prior treatment for stage III or IV disease
Must have adequate white and red blood cells and platelets.
Must be able to take Vitamin B12, Folic Acid and dexamethasone as stated in the study
Must be able to understand the nature of this study and give written informed consent
Adequate liver and kidney function

Exclusion Criteria:

Past or current history of cancer with the exception of treated non- melanoma skin cancer or carcinoma in-situ of the cervix, or other cancers cured by local therapy alone and have been disease free for five years
Female patients who are pregnant or are lactating are ineligible
History of unstable angina or myocardial infarction within 6 months prior to beginning bevacizumab
Brain metastasis - cancer that has spread to the brain
Major surgical procedure, open biopsy, or significant traumatic injury within 6 weeks of beginning bevacizumab or anticipation of need for major surgical procedure during the course of the study
Full-dose oral or by vein anticoagulation or receiving anti-clotting therapy within 10 days of starting treatment
Serious nonhealing wound, ulcer, or bone fracture
Bleeding or clotting disorders
Uncontrolled high blood pressure or serious heart arrhythmia requiring medication
History of abdominal fistula, gastrointestinal perforation, or intra- abdominal abscess within 6 months prior to beginning bevacizumab
Chronic non-steroidal anti-inflammatory use is not allowed on study
History of stroke or TIAs within the last 6 months

Please Note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have.